Correction to: Personalized Multimorbidity Management for Patients with Type 2 Diabetes Using Reinforcement Learning of Electronic Health Records.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Works matching IS 00126667 AND DT 2021 AND VI 81 AND IP 4
Results: 10
1
2
Orelabrutinib: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 4, p. 503, doi. 10.1007/s40265-021-01482-5
- By:
- Publication type:
- Article
3
BNT162b2 mRNA COVID-19 Vaccine: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 4, p. 495, doi. 10.1007/s40265-021-01480-7
- By:
- Publication type:
- Article
4
Tirbanibulin: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 4, p. 509, doi. 10.1007/s40265-021-01479-0
- By:
- Publication type:
- Article
5
Secukinumab: A Review in Psoriatic Arthritis.
- Published in:
- Drugs, 2021, v. 81, n. 4, p. 483, doi. 10.1007/s40265-021-01476-3
- By:
- Publication type:
- Article
6
Understanding the Chameleonic Breakthrough Cancer Pain.
- Published in:
- Drugs, 2021, v. 81, n. 4, p. 411, doi. 10.1007/s40265-021-01466-5
- By:
- Publication type:
- Article
7
Detecting and Targeting NTRK Fusions in Cancer in the Era of Tumor Agnostic Oncology.
- Published in:
- Drugs, 2021, v. 81, n. 4, p. 445, doi. 10.1007/s40265-020-01459-w
- By:
- Publication type:
- Article
8
Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis.
- Published in:
- Drugs, 2021, v. 81, n. 4, p. 419, doi. 10.1007/s40265-020-01458-x
- By:
- Publication type:
- Article
9
Novel Therapy Approaches to Follicular Lymphoma.
- Published in:
- Drugs, 2021, v. 81, n. 4, p. 453, doi. 10.1007/s40265-020-01446-1
- By:
- Publication type:
- Article
10
Personalized Multimorbidity Management for Patients with Type 2 Diabetes Using Reinforcement Learning of Electronic Health Records.
- Published in:
- Drugs, 2021, v. 81, n. 4, p. 471, doi. 10.1007/s40265-020-01435-4
- By:
- Publication type:
- Article